Inhibition of Monoamine Oxidase-B by Condensed Pyridazines and Pyrimidines: Effects of Lipophilicity and Structure−Activity Relationships
Citations Over TimeTop 14% of 1998 papers
Abstract
A number of condensed pyridazines and pyrimidines were synthesized and tested for their monoamine oxidase-A (MAO-A) and MAO-B inhibitory activity. Their lipophilicity was examined by measuring partition coefficients and RP-HPLC capacity factors, revealing some peculiar electronic and conformational effects. Further insights were obtained by X-ray crystallography and a thermodynamic study of RP-HPLC retention. Structure−activity relations highlighted the main factors determining both selectivity and inhibitory potency. Thus, while most of the condensed pyridazines were reversible inhibitors of MAO-B with little or no MAO-A effects, the pyrimidine derivatives proved to be reversible and selective MAO-A inhibitors. Substituents on the diazine nucleus modulated enzyme inhibition. A QSAR analysis of X-substituted 3-X-phenyl-5H-indeno[1,2-c]pyridazin-5-ones showed lipophilicity to increase MAO-B and not MAO-A inhibitory activity.
Related Papers
- → Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients(2002)98 cited
- → Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study(1991)95 cited
- → Inhibition of Monoamine Oxidase-B by Condensed Pyridazines and Pyrimidines: Effects of Lipophilicity and Structure−Activity Relationships(1998)84 cited
- → The oxidation of tryptamine by the two forms of monoamine oxidase in human tissues(1986)40 cited
- → Deamination of 5‐Hydroxytryptamine by Both Forms of Monoamine Oxidase in the Rat Brain(1982)126 cited